Actors in whitespace: Communicating risk information on pharmaceutical websites.

Amie C O'Donoghue, Helen W Sullivan, Douglas J Rupert, Jessica Fitts Willoughby, Kathryn J Aikin

Abstract readRandomized Controlled Trial

In one paragraph

Trial report in Health marketing quarterly. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

The FDA's Diverse and Dynamic Activities in the Social and Behavioral Sciences: Advancing and Supporting Health Equity.Journal of primary care & community health
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amie C O'Donoghuea U.S. Food and Drug Administration , Silver Spring , Maryland , USA.

Helen W Sullivana U.S. Food and Drug Administration , Silver Spring , Maryland , USA.

Douglas J Rupertb RTI International , Research Triangle Park , North Carolina , USA.

Jessica Fitts Willoughbyb RTI International , Research Triangle Park , North Carolina , USA.

Kathryn J Aikina U.S. Food and Drug Administration , Silver Spring , Maryland , USA.

Funding

Intramural FDA HHS FD999999

6 · The paper itself

Abstract

This study examined the use of an actor to communicate prescription drug risks on pharmaceutical websites. Participants viewed risk information for a fictitious drug in one of several static visual formats or as a paragraph plus an animated actor; and with or without a signal directing them to the risk information text. The signal had little effect on outcomes. Format did not affect risk processing, but participants in the actor condition thought the website placed less emphasis on benefits. Actors communicating risk information on a pharmaceutical website do not appear to improve consumers' understanding of prescription drug information.

Indexed as

Consumer Health InformationInternetRisk AssessmentAdultAgedDirect-to-Consumer AdvertisingDrug IndustryFemaleHumansMaleMiddle AgedPrescription DrugsSurveys and QuestionnairesPrescription DrugsAnimationdirect-to-consumer promotiononline videoprescription drugsrisk communication

Identifiers

PMID30907290

DOI10.1080/07359683.2019.1575063

PMCPMC7358773

What OpenQuestion holds

Textmetadata

LicenceTDM

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.